Joseph D. Fleming, Ph.D. - Publications
Affiliations: | 2012 | Biological Sciences in Dental Medicine | Harvard University, Cambridge, MA, United States |
Area:
Molecular Biology, Bioinformatics Biology, Cell Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Fleming JD, Giresi PG, Lindahl-Allen M, Krall EB, Lieb JD, Struhl K. STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer. Epigenetics & Chromatin. 8: 7. PMID 25784959 DOI: 10.1186/1756-8935-8-7 | 0.412 | |||
2013 | Fleming JD, Pavesi G, Benatti P, Imbriano C, Mantovani R, Struhl K. NF-Y coassociates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. Genome Research. 23: 1195-209. PMID 23595228 DOI: 10.1101/Gr.148080.112 | 0.409 | |||
2008 | Crotti TN, Sharma SM, Fleming JD, Flannery MR, Ostrowski MC, Goldring SR, McHugh KP. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter. Journal of Cellular Physiology. 215: 636-44. PMID 18288635 DOI: 10.1002/Jcp.21344 | 0.343 | |||
2006 | Crotti TN, Flannery M, Walsh NC, Fleming JD, Goldring SR, McHugh KP. NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. Gene. 372: 92-102. PMID 16513293 DOI: 10.1016/J.Gene.2005.12.012 | 0.427 | |||
Show low-probability matches. |